193 related articles for article (PubMed ID: 7737755)
1. Increased heparin-releasable platelet factor 4 and D dimer in patients one month after the onset of acute myocardial infarction: persistent activation of platelets and the coagulation/fibrinolytic system.
Abe S; Maruyama I; Arima S; Yamaguchi H; Okino H; Hamasaki S; Yamashita T; Nomoto K; Tahara M; Atsuchi Y
Int J Cardiol; 1994 Dec; 47(1 Suppl):S7-12. PubMed ID: 7737755
[TBL] [Abstract][Full Text] [Related]
2. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
Soeki T; Tamura Y; Fukuda N; Ito S
Jpn Circ J; 2000 Aug; 64(8):547-53. PubMed ID: 10952148
[TBL] [Abstract][Full Text] [Related]
3. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
[TBL] [Abstract][Full Text] [Related]
4. Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic and fibrinolytic factors.
Saito M; Nakabayashi T; Iuchi K; Ishikawa T; Kaseno K; Yoshida T; Asakura H; Matsuda T
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):801-4. PubMed ID: 7507363
[TBL] [Abstract][Full Text] [Related]
5. Activation of coagulation system in dilated cardiomyopathy: comparison of patients with and without left ventricular thrombus.
Riza Erbay A; Turhan H; Aksoy Y; Senen K; Yetkin E
Coron Artery Dis; 2004 Aug; 15(5):265-8. PubMed ID: 15238823
[TBL] [Abstract][Full Text] [Related]
6. Activation of coagulation and fibrinolysis in patients with arteriosclerosis: relation to localization of vessel disease and risk factors.
Speiser W; Speiser P; Minar E; Korninger C; Niessner H; Huber K; Schernthaner G; Ehringer H; Lechner K
Thromb Res; 1990 Jul; 59(1):77-88. PubMed ID: 2144671
[TBL] [Abstract][Full Text] [Related]
7. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
8. Clinical study of platelet function and coagulation/fibrinolysis with Duraflo II heparin coated cardiopulmonary bypass equipment.
Nakajima T; Osawa S; Ogawa M; Sasaki T; Izumoto H; Yagi Y; Kawazoe K
ASAIO J; 1996; 42(4):301-5. PubMed ID: 8828788
[TBL] [Abstract][Full Text] [Related]
9. Hemostatic abnormalities in acute myocardial infarction as detected by specific blood markers.
Tanaka M; Suzuki A
Thromb Res; 1994 Nov; 76(3):289-98. PubMed ID: 7863479
[TBL] [Abstract][Full Text] [Related]
10. Thrombin generation as an acute effect of cigarette smoking.
Kimura S; Nishinaga M; Ozawa T; Shimada K
Am Heart J; 1994 Jul; 128(1):7-11. PubMed ID: 8017287
[TBL] [Abstract][Full Text] [Related]
11. The coagulation system is activated in idiopathic cardiomyopathy.
Yamamoto K; Ikeda U; Furuhashi K; Irokawa M; Nakayama T; Shimada K
J Am Coll Cardiol; 1995 Jun; 25(7):1634-40. PubMed ID: 7539015
[TBL] [Abstract][Full Text] [Related]
12. Plasma soluble fibrin monomer complex as a marker of coronary thrombotic events in patients with acute myocardial infarction.
Ieko M; Naito S; Yoshida M; Kanazawa K; Mizukami K; Sato H; Yui T; Nakabayashi T; Hirabayashi T; Oguma Y
Tohoku J Exp Med; 2009 Sep; 219(1):25-31. PubMed ID: 19713681
[TBL] [Abstract][Full Text] [Related]
13. Effect of infective endocarditis on blood coagulation and platelet activation and comparison of patients with to those without embolic events.
Ileri M; Alper A; Senen K; Durmaz T; Atak R; Hisar I; Yetkin E; Turhan H; Demirkan D
Am J Cardiol; 2003 Mar; 91(6):689-92. PubMed ID: 12633799
[TBL] [Abstract][Full Text] [Related]
14. Changes of hemostasis, endogenous fibrinolysis, platelet activation and endothelins after percutaneous transluminal coronary angioplasty in patients with stable angina.
Borries M; Heins M; Fischer Y; Stiegler H; Peters A; Reinauer H; Schoebel FC; Strauer BE; Leschke M
J Am Coll Cardiol; 1999 Aug; 34(2):486-93. PubMed ID: 10440163
[TBL] [Abstract][Full Text] [Related]
15. Fluctuation of thrombin-antithrombin III complex in patients with acute myocardial infarction: influence of low-dose heparin administration.
Psuja P; Lewandowski K; Turowiecka Z; ZozuliĆska M; Tokarz A; Zawilska K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):229-36. PubMed ID: 1697824
[TBL] [Abstract][Full Text] [Related]
16. Thrombosis and fibrinolysis in acute myocardial infarction.
Eisenberg PR
Alcohol Clin Exp Res; 1994 Feb; 18(1):97-104. PubMed ID: 8198233
[TBL] [Abstract][Full Text] [Related]
17. Circadian variations of plasma levels of blood coagulation/fibrinolysis molecular markers in progressive systemic sclerosis (PSS).
Maeda M; Kachi H; Kitajima Y
J Dermatol Sci; 1996 Oct; 13(1):18-24. PubMed ID: 8902649
[TBL] [Abstract][Full Text] [Related]
18. Late activation of the fibrinolytic system in myocardial infarction treated with thrombolytic therapy. Influence of the coronary anatomical substrate.
Salvioni A; Perego GB; Marenzi G; Lauri G; Giraldi F; Grazi S; Guazzi MD
Eur Heart J; 1996 Feb; 17(2):230-6. PubMed ID: 8732376
[TBL] [Abstract][Full Text] [Related]
19. Activation of thrombosis and fibrinolysis following brain infarction.
Kataoka S; Hirose G; Hori A; Shirakawa T; Saigan T
J Neurol Sci; 2000 Dec; 181(1-2):82-8. PubMed ID: 11099716
[TBL] [Abstract][Full Text] [Related]
20. [A clinical study on hemostatic fluctuation during and after cardiopulmonary bypass using hemostatic molecular markers].
Nakajima H
Nihon Kyobu Geka Gakkai Zasshi; 1992 Nov; 40(11):1987-97. PubMed ID: 1336789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]